Teza Capital Management LLC decreased its position in Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 59.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,918 shares of the company’s stock after selling 20,493 shares during the period. Teza Capital Management LLC’s holdings in Nu Skin Enterprises were worth $101,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC lifted its holdings in Nu Skin Enterprises by 64.6% in the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company’s stock valued at $2,530,000 after buying an additional 137,475 shares during the period. Amundi lifted its holdings in Nu Skin Enterprises by 18.8% in the first quarter. Amundi now owns 18,564 shares of the company’s stock valued at $127,000 after buying an additional 2,941 shares during the period. PDT Partners LLC raised its holdings in shares of Nu Skin Enterprises by 68.3% during the first quarter. PDT Partners LLC now owns 41,202 shares of the company’s stock valued at $299,000 after purchasing an additional 16,723 shares during the period. Graham Capital Management L.P. raised its holdings in shares of Nu Skin Enterprises by 12.7% during the first quarter. Graham Capital Management L.P. now owns 117,103 shares of the company’s stock valued at $850,000 after purchasing an additional 13,160 shares during the period. Finally, Ieq Capital LLC acquired a new position in shares of Nu Skin Enterprises during the first quarter valued at about $279,000. Institutional investors and hedge funds own 82.84% of the company’s stock.
Insider Transactions at Nu Skin Enterprises
In other news, EVP Chayce David Clark sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total transaction of $239,400.00. Following the completion of the sale, the executive vice president directly owned 233,140 shares of the company’s stock, valued at $2,790,685.80. The trade was a 7.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Daniel W. Campbell sold 23,391 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the sale, the director directly owned 53,375 shares of the company’s stock, valued at approximately $645,837.50. The trade was a 30.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 58,926 shares of company stock valued at $711,364 over the last three months. Corporate insiders own 2.00% of the company’s stock.
Nu Skin Enterprises Trading Up 1.0%
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.25 by $0.18. The company had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, equities research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 10th. Stockholders of record on Friday, August 29th will be given a dividend of $0.06 per share. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.24 annualized dividend and a dividend yield of 2.1%. Nu Skin Enterprises’s payout ratio is presently 11.94%.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on NUS shares. Zacks Research upgraded shares of Nu Skin Enterprises to a “hold” rating in a report on Tuesday, August 12th. Wall Street Zen lowered shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Friday, September 5th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $6.88.
View Our Latest Research Report on NUS
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles
- Five stocks we like better than Nu Skin Enterprises
- Bank Stocks – Best Bank Stocks to Invest In
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- When to Sell a Stock for Profit or Loss
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.